Discovery of a potent catalytic p300/CBP inhibitor that targets lineage-specific tumors

被引：0

作者：

Bromberg, Kenneth D. ^{[1
]}

Lasko, Loren M. ^{[1
]}

Jakob, Clarissa G. ^{[1
]}

Qiu, Wei ^{[1
]}

Montgomery, Debra ^{[1
]}

Digiammarino, Enrico L. ^{[1
]}

Hansen, Todd M. ^{[1
]}

Risi, Roberto M. ^{[1
]}

Frey, Robin R. ^{[1
]}

Manaves, Vlasios ^{[1
]}

Shaw, Bailin ^{[1
]}

Algire, Mikkel ^{[1
]}

Hessler, Paul ^{[1
]}

Lam, Lloyd T. ^{[1
]}

Uziel, Tamar ^{[1
]}

Favire, Emily ^{[1
]}

Ferguson, Debra ^{[1
]}

Buchanan, Fritz G. ^{[1
]}

Martin, Ruth L. ^{[1
]}

Torrent, Maricel ^{[1
]}

Rosenberg, Saul H. ^{[1
]}

Michaelides, Michael R. ^{[1
]}

Lai, Albert ^{[1
]}

机构：

[1] AbbVie Inc, N Chicago, IL USA

来源：

MOLECULAR CANCER THERAPEUTICS | 2018年 / 17卷 / 01期

关键词：

D O I：

10.1158/1535-7163.TARG-17-LB-A23

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LB-A23

引用

页数：2

共 50 条

[1] Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
Lasko, Loren M.
Jakob, Clarissa G.
Edalji, Rohinton P.
Qiu, Wei
Montgomery, Debra
Digiammarino, Enrico L.
Hansen, T. Matt
Risi, Roberto M.
Frey, Robin
Manaves, Vlasios
Shaw, Bailin
Algire, Mikkel
Hessler, Paul
Lam, Lloyd T.
Uziel, Tamar
Faivre, Emily
Ferguson, Debra
Buchanan, Fritz G.
Martin, Ruth L.
Torrent, Maricel
Chiang, Gary G.
Karukurichi, Kannan
Langston, J. William
Weinert, Brian T.
Choudhary, Chunaram
de Vries, Peter
Van Drie, John H.
McElligott, David
Kesicki, Ed
Marmorstein, Ronen
Sun, Chaohong
Cole, Philip A.
Rosenberg, Saul H.
Michaelides, Michael R.
Lai, Albert
Bromberg, Kenneth D.
NATURE, 2017, 550 (7674) : 128 - +
[2] Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
Loren M. Lasko
Clarissa G. Jakob
Rohinton P. Edalji
Wei Qiu
Debra Montgomery
Enrico L. Digiammarino
T. Matt Hansen
Roberto M. Risi
Robin Frey
Vlasios Manaves
Bailin Shaw
Mikkel Algire
Paul Hessler
Lloyd T. Lam
Tamar Uziel
Emily Faivre
Debra Ferguson
Fritz G. Buchanan
Ruth L. Martin
Maricel Torrent
Gary G. Chiang
Kannan Karukurichi
J. William Langston
Brian T. Weinert
Chunaram Choudhary
Peter de Vries
Arthur F. Kluge
Michael A. Patane
John H. Van Drie
Ce Wang
David McElligott
Ed Kesicki
Ronen Marmorstein
Chaohong Sun
Philip A. Cole
Saul H. Rosenberg
Michael R. Michaelides
Albert Lai
Kenneth D. Bromberg
Nature, 2017, 550 : 128 - 132
[3] Author Correction: Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
Loren M. Lasko
Clarissa G. Jakob
Rohinton P. Edalji
Wei Qiu
Debra Montgomery
Enrico L. Digiammarino
T. Matt Hansen
Roberto M. Risi
Robin Frey
Vlasios Manaves
Bailin Shaw
Mikkel Algire
Paul Hessler
Lloyd T. Lam
Tamar Uziel
Emily Faivre
Debra Ferguson
Fritz G. Buchanan
Ruth L. Martin
Maricel Torrent
Gary G. Chiang
Kannan Karukurichi
J. William Langston
Brian T. Weinert
Chunaram Choudhary
Peter de Vries
Arthur F. Kluge
Michael A. Patane
John H. Van Drie
Ce Wang
David McElligott
Edward A. Kesicki
Ronen Marmorstein
Chaohong Sun
Philip A. Cole
Saul H. Rosenberg
Michael R. Michaelides
Albert Lai
Kenneth D. Bromberg
Nature, 2018, 558 : E1 - E1
[4] Discovery of a selective catalytic p300/CBP inhibitor that targets lineage specific tumours (vol 550, pg 128, 2017)
Lasko, Loren M.
Jakob, Clarissa G.
Edalji, Rohinton P.
Qiu, Wei
Montgomery, Debra
Digiammarino, Enrico L.
Hansen, T. Matt
Risi, Roberto M.
Frey, Robin
Manaves, Vlasios
Shaw, Bailin
Algire, Mikkel
Hessler, Paul
Lam, Lloyd T.
Uziel, Tamar
Faivre, Emily
Ferguson, Debra
Buchanan, Fritz G.
Martin, Ruth L.
Torrent, Maricel
Chiang, Gary G.
Karukurichi, Kannan
Langston, J. William
Weinert, Brian T.
Choudhary, Chunaram
de Vries, Peter
Kluge, Arthur F.
Patane, Michael A.
Van Drie, John H.
Wang, Ce
McElligott, David
Kesicki, Edward A.
Marmorstein, Ronen
Sun, Chaohong
Cole, Philip A.
Rosenberg, Saul H.
Michaelides, Michael R.
Lai, Albert
Bromberg, Kenneth D.
NATURE, 2018, 558 (7710) : E1 - E1
[5] Discovery of a Potent and Selective Covalent p300/CBP Inhibitor
Mastracchio, Anthony
Lai, Chunqiu
Digiammarino, Enrico
Ready, Damien B.
Lasko, Loren M.
Bromberg, Kenneth D.
McClellan, William J.
Montgomery, Debra
Manaves, Vlasios
Shaw, Bailin
Algire, Mikkel
Patterson, Melanie J.
Sun, Chaohong C.
Rosenberg, Saul
Lai, Albert
Michaelides, Michael R.
ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (05): : 726 - 731
[6] Lineage-specific signaling in melanocytes - c-Kit stimulation recruits p300/CBP to microphthalmia
Price, ER
Ding, HF
Badalian, T
Bhattacharya, S
Takemoto, C
Yao, TP
Hemesath, TJ
Fisher, DE
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (29) : 17983 - 17986
[7] Another One (of the "Undruggable" Targets) Bites the Dust: Discovery of a Potent and Selective Inhibitor of the Histone Acetyl Transferase p300/CBP
Kodadek, Thomas
BIOCHEMISTRY, 2018, 57 (06) : 899 - 900
[8] Discovery of HP537, a potent and selective p300/CBP inhibitor for the treatment of hematologic malignancies
Li, Jing
Tu, Zhilin
Peng, Jian
Fan, Lei
Yu, Hua
Wang, Fei
Li, Xinghai
CANCER RESEARCH, 2024, 84 (07)
[9] Discovery and biological evaluation of thiobarbituric derivatives as potent p300/CBP inhibitors
Lu, Wenchao
Xiong, Huan
Chen, Yu
Wang, Chen
Zhang, Hao
Xu, Pan
Han, Jie
Xiao, Senhao
Ding, Hong
Chen, Zhifeng
Lu, Tian
Wang, Jun
Zhang, Yuanyuan
Yue, Liyan
Liu, Yu-Chih
Zhang, Chenhua
Yang, Yaxi
Jiang, Hualiang
Chen, Kaixian
Zhou, Bing
Luo, Cheng
BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (20) : 5397 - 5407
[10] Targeting Lineage-specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small-molecule Inhibitor of p300/CBP
Wang, Rui
He, Yupeng
Robinson, Valerie
Yang, Ziping
Hessler, Paul
Lasko, Loren M.
Lu, Xin
Bhathena, Anahita
Lai, Albert
Uziel, Tamar
Lam, Lloyd T.
MOLECULAR CANCER THERAPEUTICS, 2018, 17 (12) : 2543 - 2550

← 1 2 3 4 5 →